✦ LIBER ✦

Formestane: 250mg vs 500mg in relapsed breast cancer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

NEWEST: a Phase II, randomised, neoadjuv

✍ C. Singer; I. Kuter; R. Hegg; R. Badwe; N. Harbeck; J. Bines; E. Lowe 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Results of the CONFIRM Phase III Trial C

✍ Jordan, V.C. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Single dose evaluation of efficacy and s

✍ D.R. Mehlisch; W. Sterling; F. Mazza; P. Brown 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Effects of fulvestrant 250 mg in pr

✍ J.F.R. Robertson; V. Semiglazov; G. Nemsadze; G. Dzagnidze; M. Janjalia; R.I. Ni 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 127 KB

Phase II study of low dose aminoglutethi

✍ Harris, Adrian L.; Cantwell, Brian M.J.; Carmichael, James; Dawes, Peter; Robins 📂 Article 📅 1989 🏛 Elsevier Science ⚖ 712 KB

Comparative bioavailability study of cap

✍ Gadiko, Chaitanya; Tippabhotla, Sudhakar K.; Thota, Satyanarayana; Battula, Rama 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 640 KB